Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus

MLA

David M. Patrick, et al. “Isolevuglandins Disrupt PU.1-Mediated C1q Expression and Promote Autoimmunity and Hypertension in Systemic Lupus Erythematosus.” JCI Insight, vol. 7, no. 15, Sept. 2022. EBSCOhost, https://doi.org/10.1172/jci.insight.163757.

APA

David M. Patrick, Néstor de la Visitación, Jaya Krishnan, Wei Chen, Michelle J. Ormseth, C. Michael Stein, Sean S. Davies, Venkataraman Amarnath, Leslie J. Crofford, Jonathan M. Williams, Shilin Zhao, Charles D. Smart, Sergey Dikalov, Anna Dikalova, Liang Xiao, Justin P. Van Beusecum, Mingfang Ao, Agnes B. Fogo, Annet Kirabo, & David G. Harrison. (2022). Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus. JCI Insight, 7(15). https://doi.org/10.1172/jci.insight.163757

Chicago

David M. Patrick, Néstor de la Visitación, Jaya Krishnan, Wei Chen, Michelle J. Ormseth, C. Michael Stein, Sean S. Davies, et al. 2022. “Isolevuglandins Disrupt PU.1-Mediated C1q Expression and Promote Autoimmunity and Hypertension in Systemic Lupus Erythematosus.” JCI Insight 7 (15). doi:10.1172/jci.insight.163757.